BRIEF-Japan Tobacco, Torii sign agreement to market 2 new TAF-based anti-HIV drugs in Japan

* Signed agreement with Torii Pharmaceutical Co to market two new tenofovir alafenamide (TAF)-based anti-HIV drugs in Japan
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.